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Disease prevalence mapping allows 
countries to identify infected individuals 
and populations in need of disease-
control measures, such as mass drug 
administration (MDA) with preventive 
chemotherapy. For countries with 
unlimited time and resources, disease-
specific prevalence mapping may be 
carried out in a slow, careful manner, by 
large teams of diagnostic technicians, 
supervisors, and drivers. These mapping 
protocols, established by the World 
Health Organization (WHO), are intended 
to be carried out independently, by each 
respective disease-control programme, in 
order to assess prevalence of neglected 
tropical diseases (NTDs) in individual 
populations. They work particularly well in 
areas endemic for one NTD. 
In reality, the countries most affected 
by NTDs have limited resources for 
mapping, and are endemic for two or 
more NTDs, for example lymphatic 
filariasis (LF), and/or trachoma, and/or 
schistosomiasis and/or soil transmitted 
helminths (STH). For these countries, with 
efficiency and field-practicality in mind, 
the coordinated threshold mapping (CTM) 
method was developed. The method 
enables coordinators from two or more 
disease programmes to work together to 
determine the prevalence of two or more 
diseases in a population, at one time. The 
CTM method achieves the same goals as 
the WHO’s disease-specific protocols, 
namely identifying the need for MDA with 
preventive chemotherapy. It does not 
provide prevalence figures, but instead 
aims to determine whether a disease has 
attained the threshold necessitating a 
public health intervention.1 Therefore, 
rather than carrying out simultaneous, 
independent mapping efforts in areas 
endemic for more than two NTDs, at a 
high cost to the national control 
programmes, the CTM method saves 
countries precious time (smaller sampling 
size) and resources (fewer survey team 
members). Table 1 gives a comparison of 
disease-specific prevalence mapping and 
CTM. 
It is the responsibility of a national-
level coordinator to work together with the 
coordinators of the various NTD control 
programmes to compile historic data that 
will determine areas where NTDs are 
suspected to be endemic. Once the areas 
in need of NTD prevalence mapping have 
been identified, a protocol is agreed 
upon at the national level. In the CTM 
method, each disease module uses the 
WHO-recommended standard indicators 
and diagnostic methods (Table 2), and is 
field-tested and independent. As such, a 
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  Disease-specific prevalence mapping Coordinated threshold mapping (CtM)
Advantages • Workers in each disease programme are 
accustomed to working independently, 
managing their own budgets and personnel
• Diseases differ in their geographical distribution; 
some are more localised (schistosomiasis, 
onchocerciasis) while others occur widely 
(trachoma, soil-transmitted helminths, 
lymphatic filariasis)
• Produces disease prevalence data for trachoma
• Reveals whether threshold for public health 
intervention has been surpassed
• Workers share logistical responsibilities, reducing the 
burden on each programme and allowing them to 
achieve disease-specific, non-mapping objectives
• Employs smaller survey teams thus encouraging each 
team member to perform multiple tasks – saving money 
and better utilising broadly trained technicians
• Reveals and improves understanding of occurrence of 
co-infections among individuals within the population
• Unites NTD control programmes with respect to public
• Encourages involvement of community members – 
building local capacity and local advocacy
• Reveals whether threshold for public health intervention 
has been surpassed
Disadvantages • Mapping efforts must be mobilised independently
• Each NTD control coordinator has responsibility 
of disease mapping
• Does not produce precise prevalence data for trachoma
• Increases responsibility of all survey team members
After giving stool and urine samples (to detect soil-transmitted helminths and 
schistosomiasis, respectively) the children are checked for signs of trachoma. tOGO
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protocol is built to suit the particular 
mapping needs of a country simply by 
adding each of the disease modules 
together as needed. Mapping needs 
within a country may differ by region or 
district, which can easily be accommo-
dated within the CTM. 
Next, a CTM team is formed, including: 
one supervisor (usually selected from 
among the national-level NTD-control 
programme coordinators), and one or two 
diagnostic technicians per NTD to be 
mapped. The team members are selected 
for their demonstrated expertise and 
independence in NTD diagnosis, as well 
as for their prior field experience and 
enthusiasm for collaboration. Team members 
will be trained in CTM methodology, 
sampling, questionnaires, data collection 
tools, and in obtaining informed consent. 
The CTM team (supervisor and 
diagnostic technicians) travels in one 
vehicle to survey two villages in each 
subdistrict each day. Depending on which 
diseases are being mapped, some combi-
nation of the following activities takes 
place: trachoma examinations, stool 
collection, urinalysis, and LF testing 
(during the day) as well as examination of 
stool samples (Kato-Katz method) in the 
evening. Community health workers, 
teachers, and village chiefs are encouraged 
by the NTD control programme coordi-
nators to assist with bringing participants 
to a central location, then organising and 
registering them. This participation of 
local volunteers has been shown to build 
local capacity and spontaneous local 
advocacy for co-ordinated NTD control.6
Co-ordinated (or integrated) mapping 
surveys have been successfully imple-
mented in several countries, including for 
schistosomiasis and trachoma in Nigeria7, 
for schistosomiasis, STH and trachoma in 
Togo6; for LF, loiasis, schistosomiasis and 
STH in South Sudan8,9, for trachoma, LF, 
schistosomiasis and STH in Mali and 
Senegal1; and for schistosomiasis and 
STH in Cameroon.10 
Although CTM offers several important 
advantages over the WHO’s disease-
specific protocol for countries that are 
endemic for more than one NTD, the 
method is not without shortcomings 
(Table 1). However, the various NTD 
programmes share the common goal of a 
healthier, more productive population. By 
working together in disease mapping, this 
common goal is more attainable. In our 
experience, the initial reluctance towards 
collaboration among different NTD 
programmes was eased as members quickly 
noticed improved efficiency compared to 
disease-specific methodologies.1
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Disease Diagnostic method thresholds for different public health interventions
trachoma2 Clinical examination using the WHO Simplified 
Trachoma Grading System
Follicular trachoma (TF) present in ≥10% of 
children examined (1–9 years old)
TF  in ≥5 of children examined (1–9 years old)
Trichiasis present in ≥1% of adults (≥15 years old)
Onchocerciasis3 The prevalence of nodules is determined via the 
rapid epidemiological mapping method (REMO); 
or the presence of Onchocerca volvulus 
microfilaria is determined via skin snip
For control: presence of palpable nodules in ≥20% 
of adults tested (≥15 years old)
For elimination: prevalence of palpable nodules in 
≥5% of adults tested (≥15 years old)
Lymphatic filariasis 
(LF)4
Immuno-chromatographic card test (ICT) to 
determine the presence of daytime antigenemia
Present in ≥1% of adults tested (≥15 years old)
Soil-transmitted 
helminths (StH)5
Kato-Katz method to look for presence of eggs in 
stool
Present in ≥50% of children tested (5–14 years old)
Present in  ≥20% and <50% of children tested 
(aged 5-14 years) 
Schistosomiasis5 Schistosoma mansoni:
Kato-Katz method to look for presence of eggs in 
stool.
Schistosoma haematobium:
Reagent strips (urinalysis) to look for blood in 
urine and administer questionnaire or urine 
filtration to look for eggs in urine
Present in ≥50% of children tested (aged 5–14 
years) if based on parasitological methods; or 
≥30% if based on questionnaires for visible 
haematuria 
Present in ≥10% and <50% if parasitological 
methods; or >1% and <30% if based on 
questionnaire for visible haematuria in children 
aged 5–14 years
Present in ≥1% and <10% (if based on 
parasitological methods) in children aged 5–14 years
Table 2: Diagnostic methods thresholds used in coordinated threshold mapping (CTM). These are the same as those recommended 
by the WHO, except for trachoma: the protocol for this disease was adapted in collaboration with the International Trachoma Initiative
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